No headlines found.
/C O R R E C T I O N -- BGM Group Ltd/
PRNewswire (Fri, 29-Nov 10:59 AM ET)
PRNewswire (Fri, 29-Nov 10:11 AM ET)
PRNewswire (Fri, 29-Nov 9:00 AM ET)
Globe Newswire (Fri, 29-Nov 9:00 AM ET)
BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development
PRNewswire (Fri, 22-Nov 8:30 AM ET)
Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd.
PRNewswire (Tue, 29-Oct 8:00 AM ET)
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.
BGM Group Ltd. - Class A trades on the NASDAQ stock market under the symbol BGM.
As of December 13, 2024, BGM stock price climbed to $8.68 with 6,652 million shares trading.
BGM has a beta of 1.82, meaning it tends to be more sensitive to market movements. BGM has a correlation of 0.13 to the broad based SPY ETF.
BGM has a market cap of $236.33 million. This is considered a Small Cap stock.
BGM support price is $7.96 and resistance is $9.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BGM shares will trade within this expected range on the day.